McDonald succeeds Lafley as P&G chairman: A.G. Lafley hands over the reins as Procter & Gamble chairman to Bob McDonald on Jan. 1, 2010 - almost two months before he will retire. The move is part of a phased-in leadership transition that began in June when Lafley passed the president and CEO baton to McDonald (1"The Tan Sheet" June 15, 2009). In the 10 years Lafley was president and CEO, Cincinnati-based P&G doubled its sales and grew its portfolio of billion-dollar brands from 10 to 22, according to a Dec. 8 release. ... WellPoint's Braly joins board: In a same-day release, P&G says it appointed WellPoint President and CEO Angela F. Braly to its board effective immediately. WellPoint, a health benefits provider with 34 million members, has initiated coverage for OTC products in some areas (2"The Tan Sheet" May 26, 2008)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.
In this first in a series of articles looking at the potential impact of the MFN drug pricing policy on European pharmaceutical markets, EUCOPE’s Alexander Natz tells the Pink Sheet why the US policy underscores the importance of confidential net pricing.
The International Council for Harmonisation has identified four new topics that can benefit from global regulatory alignment, with timelines for initiating work to be determined later.